Target Name: Transcription factor AP-2
NCBI ID: P12325
Review Report on Transcription factor AP-2 Target / Biomarker Content of Review Report on Transcription factor AP-2 Target / Biomarker
Transcription factor AP-2
Other Name(s): None

Regulating Cellular Processes: AP-2's Role in Gene Expression and Cell Biology

Transcription factor AP-2 (nonspecified subtype) is a protein that plays a crucial role in gene expression and cell biology. It is a key regulator of gene expression, and is involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis.

AP-2 is a member of the AP-1 family of transcription factors, which are characterized by the presence of a nucleotide-binding oligomerization domain (NBD) and a T-cell response factor 1 (TFR1) domain. The NBD is a protein-coding region that is responsible for binding to specific DNA sequences, while the TFR1 domain is a protein-coding region that is involved in the regulation of DNA binding and gene expression.

AP-2 is a transcriptional regulator that is involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. It is a key regulator of the cell cycle, and is involved in the regulation of the G1 phase, S phase, and G2 phase of cell division.

AP-2 is also involved in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. During apoptosis, AP-2 plays a key role in the regulation of various cellular processes, including the production of pro-inflammatory cytokines, the release of mitochondrial enzymes, and the formation of apoptotic bodies.

AP-2 is a potential drug target, due to its involvement in the regulation of cellular processes that are important for human health and disease. For example, altered levels of AP-2 have been associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its involvement in cellular processes, AP-2 is also a potential biomarker for a variety of diseases. For example, altered levels of AP-2 have been associated with the development of certain cancers, and may be a useful biomarker for these diseases.

Overall, AP-2 is a protein that is involved in the regulation of various cellular processes and is a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in gene expression and cell biology, and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Transcription Factor AP-2 (nonspecified Subtype)

The "Transcription factor AP-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Transcription factor AP-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Transcription factor GATA | Transcription factor Maf | Transcription factor NF-E2 | Transcription factor SOX | Transcription Factor TCF | Transcription factor TFIIIB complex | Transcriptional Enhancer Factor (TEAD) (nonspecified subype) | Transfer RNA methionine (anticodon CAU) | Transforming growth factor | Transforming growth factor (TGF)-beta receptor | Transforming growth factor beta | Transglutaminase | Transient Receptor Potential Cation Channel (TRP) | Transient receptor potential cation channel subfamily V | Translation initiation factor IF-2-like, transcript variant X1 | Translocase of inner mitochondrial membrane 23 homolog B (yeast), transcript variant X1 | Translocon-associated protein (TRAP) complex | Transmembrane protein FLJ37396 | TRAP1 | TRAPP complex | TRAPPC1 | TRAPPC10 | TRAPPC11 | TRAPPC12 | TRAPPC13 | TRAPPC14 | TRAPPC2 | TRAPPC2L | TRAPPC3 | TRAPPC3L | TRAPPC4 | TRAPPC5 | TRAPPC6A | TRAPPC6B | TRAPPC8 | TRAPPC9 | TRARG1 | TRAT1 | TRAV1-2 | TRAV10 | TRAV11 | TRAV12-1 | TRAV12-2 | TRAV13-2 | TRAV14DV4 | TRAV19 | TRAV2 | TRAV20 | TRAV21 | TRAV22 | TRAV24 | TRAV25 | TRAV26-1 | TRAV26-2 | TRAV27 | TRAV3 | TRAV34 | TRAV38-2DV8 | TRAV39 | TRAV4 | TRAV41 | TRAV8-1 | TRAV8-2 | TRAV8-3 | TRAV8-4 | TRAV8-6 | TRAV9-1 | TRBC1 | TRBC2 | TRBD1 | TRBD2 | TRBJ1-1 | TRBJ1-2 | TRBJ1-3 | TRBJ1-4 | TRBJ1-5 | TRBJ1-6 | TRBJ2-1 | TRBJ2-2 | TRBJ2-2P | TRBJ2-3 | TRBJ2-4 | TRBJ2-5 | TRBJ2-6 | TRBJ2-7 | TRBV10-1 | TRBV10-2 | TRBV10-3 | TRBV11-1 | TRBV11-2 | TRBV11-3 | TRBV12-3 | TRBV12-4 | TRBV12-5 | TRBV13 | TRBV14 | TRBV15 | TRBV16 | TRBV17 | TRBV18